Financial Performances - 프로스테믹스
 
 

Balance Sheet - Settlement

Finance Label 2019 2018 2017
Price Composition Increase Price Composition Increase Price Composition Increase
total current assets 14,729 46.1% 8.6% 16,118 48.6% 16.2% 19,238 47% 33.8%
total non-current assets 17,251 53.9% 1.3% 17,034 51.4% 21.5% 21,699 53% 20.9%
total assets 31,981 100% 3.5% 33,153 100% 19% 40,937 100% 12.9%
total current liabilities 1,525 4.8% 38% 1,105 3.3% 4.1% 1,061 2.6% 41.3%
total non-current liabilities 1,897 5.9% 819.9% 206 .6% 11.9% 234 .6% 7%
total liabilities 3,421 10.7% 161% 1,311 4% 1.2% 1,295 3.2% 36.1%
capital stocks 4,568 14.3% 0.7% 4,537 13.7% 0.5% 4,517 11% 0%
capital surplus 9,032 28.2% 10.1% 8,203 24.7% 2.9% 7,971 19.5% 75.8%
retained earnings 17,721 55.4% 10.8% 19,877 60% 25.6% 26,705 65.2% 498.6%
total stockholders' equity 28,559 89.3% 10.3% 31,842 96% 19.7% 39,642 96.8% 11.9%

Income Statement - Settlement

Finance Label 2019 2018 2017
Price Composition Increase Price Composition Increase Price Composition Increase
sales(net) 6,828 100% 47.2% 4,638 100% 23% 6,022 100% 57.8%
gross profit 4,363 63.9% 185.8% 1,527 32.9% 56.9% 3,540 58.8% 67.7%
operating income -2,006 -29.4% 57.6% -4,736 -102.1% 14.4% -4,140 -68.7% 194.6%
non-operating income 590 8.6% 10.9% 662 14.3% 41.8% 467 7.8% 62.4%
non-operating expenses 827 12.1% 48.2% 1,598 34.5% 147.7% 645 10.7% 12.8%
net income -2,912 -42.6% 57.4% -6,830 -147.3% 136.2% -2,892 -48% 164.2%

Cash Flow Statement - Settlement

Finance Label 2019 2018 2017
Price Increase Price Increase Price Increase
cash flows from operating activities -269 88% -2,236 29.5% -3,174 150.8%
cash flows from investing activities 1,406 3313.7% -44 100.5% 8,778 199.3%
cf from financing act. 471 6.4% 504 115.2% -3,307 0%
increases(decreases) in cash 1,609 190.6% -1,776 177.3% 2,297 188.8%
cash at the beginning of the period 3,985 29.7% 5,668 62.2% 3,495 41%
cash at the end of the period 5,554 39.4% 3,985 29.7% 5,668 62.2%
English